121 related articles for article (PubMed ID: 26526729)
21. In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.
Krátký M; Vinšová J; Buchta V
Med Chem; 2012 Jul; 8(4):732-41. PubMed ID: 22548336
[TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
23. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
24. New pyridine derivatives as potential antimicrobial agents.
Klimesová V; Svoboda M; Waisser K; Pour M; Kaustová J
Farmaco; 1999 Oct; 54(10):666-72. PubMed ID: 10575735
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antimicrobial activity of new 6-phenylimidazo[2,1-b]thiazole derivatives.
Ulusoy N; Capan G; Otük G; Kiraz M
Boll Chim Farm; 2000; 139(4):167-72. PubMed ID: 11059099
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.
Lee IY; Gruber TD; Samuels A; Yun M; Nam B; Kang M; Crowley K; Winterroth B; Boshoff HI; Barry CE
Bioorg Med Chem; 2013 Jan; 21(1):114-26. PubMed ID: 23211970
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease.
Al-Khattaf FS; Mani A; Atef Hatamleh A; Akbar I
J Infect Public Health; 2021 Apr; 14(4):533-542. PubMed ID: 33744741
[TBL] [Abstract][Full Text] [Related]
28. Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile.
Salem MS; Ali MA
Biol Pharm Bull; 2016; 39(4):473-83. PubMed ID: 27040621
[TBL] [Abstract][Full Text] [Related]
29. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
31. Microwave assisted, one-pot synthesis of 5-nitro- 2-aryl substituted-1H-benzimidazole libraries: screening in vitro for antimicrobial activity.
Hosamani KM; Seetharamareddy HR; Keri RS; Hanamanthagouda MS; Moloney MG
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1095-100. PubMed ID: 19772484
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
Khan IH; Patel NB; Patel VM
Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819
[TBL] [Abstract][Full Text] [Related]
33. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.
Jandourek O; Tauchman M; Paterova P; Konecna K; Navratilova L; Kubicek V; Holas O; Zitko J; Dolezal M
Molecules; 2017 Feb; 22(2):. PubMed ID: 28157178
[TBL] [Abstract][Full Text] [Related]
35. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold.
Krátký M; Vinšová J; Volková M; Buchta V; Trejtnar F; Stolaříková J
Eur J Med Chem; 2012 Apr; 50():433-40. PubMed ID: 22365879
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, in Vitro and in Silico Studies of Some Novel 5-Nitrofuran-2-yl Hydrazones as Antimicrobial and Antitubercular Agents.
Abdel-Aziz HA; Eldehna WM; Fares M; Elsaman T; Abdel-Aziz MM; Soliman DH
Biol Pharm Bull; 2015; 38(10):1617-30. PubMed ID: 26155871
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antimicrobial activity of some 5-substituted-3-phenyl-Nbeta-(substituted-2-oxo-2H-pyrano[2,3-b]quinoline-3-carbonyl)-1H-indole-2-carboxyhydrazide.
Suliphal Devara Mathada B; Bennikallu Hire Mathada M
Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):557-60. PubMed ID: 19483333
[TBL] [Abstract][Full Text] [Related]
39. N/C-4 substituted azetidin-2-ones: synthesis and preliminary evaluation as new class of antimicrobial agents.
Halve AK; Bhadauria D; Dubey R
Bioorg Med Chem Lett; 2007 Jan; 17(2):341-5. PubMed ID: 17098426
[TBL] [Abstract][Full Text] [Related]
40. Antimycobacterial and antimicrobial study of new 1,2,4-triazoles with benzothiazoles.
Patel NB; Khan IH; Rajani SD
Arch Pharm (Weinheim); 2010 Nov; 343(11-12):692-9. PubMed ID: 21110343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
